Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C5orf17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NLRP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CD79B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TFAP2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAS1RR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAWR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SZRD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MFAP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFMBT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSTM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC401312 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP100 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBFB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM132C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on